Mersana Therapeutics, Inc. (NASDAQ:MRSN) Consensus Forecasts Have Become A Little Darker Since Its Latest Report [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Mersana Therapeutics, Inc. (MRSN)
Last mersana therapeutics, inc. earnings: 2/28 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
mersana.com/about-mersana
Company Research
Source: Yahoo! Finance
The company still lost a statutory US$0.16 per share, although the losses were 14% smaller than the analysts expected. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year. See our latest analysis for Mersana Therapeutics Taking into account the latest results, the seven analysts covering Mersana Therapeutics provided consensus estimates of US$35.2m revenue in 2024, which would reflect an uncomfortable 8.2% decline over the past 12 months. The loss per share is expected to greatly reduce in the near future, narrowing 38% to US$0.68. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$39.1m and losses of US$0.66 per share in 2024. Overall it looks as though the analysts are negative in thi
Show less
Read more
Impact Snapshot
Event Time:
MRSN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRSN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRSN alerts
High impacting Mersana Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
MRSN
News
- Mersana Therapeutics to Present at Upcoming Investor ConferencesGlobeNewswire
- Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial ResultsGlobeNewswire
- Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
MRSN
Earnings
- 5/9/24 - Beat
MRSN
Sec Filings
- 6/12/24 - Form 4
- 6/12/24 - Form 4
- 6/12/24 - Form 4
- MRSN's page on the SEC website